HCPCS Level II
J3247
Injection, secukinumab, intravenous, 1 mg
Codes near J3247
These sit next to J3247 in the CMS Level II file. All J codes
- J3241Injection, teprotumumab-trbw, 10 mg
- J3243Injection, tigecycline, 1 mg
- J3244Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
- J3245Injection, tildrakizumab, 1 mg
- J3246Injection, tirofiban hcl, 0.25 mg
- J3250Injection, trimethobenzamide hcl, up to 200 mg
- J3260Injection, tobramycin sulfate, up to 80 mg
- J3262Injection, tocilizumab, 1 mg
- J3263Injection, toripalimab-tpzi, 1 mg
- J3265Injection, torsemide, 10 mg/ml
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00078-1168-61 | Cosentyx | Novartis Pharmaceuticals Corporation | 125 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.